The present invention provides AA targeting compounds which comprise AA targeting agent-linker conjugates which are linked to a combining site of an antibody. Various uses of the compounds are provided, including methods to treat disorders connected to abnormal angiogenesis.

 
Web www.patentalert.com

< Use of aspartic proteases in cosmetics and therapeutics

> HIV-specific CTL inducing peptides and medicaments for preventing or treating AIDS comprising the peptides

> Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
~ 00514